Conditional deletion of Bmpr1a in differentiated osteoclasts increases osteoblastic bone formation, increasing volume of remodeling bone in mice

Journal of Bone and Mineral Research

Volumn 26, Issue 10, 2011, Pages 2511-2522

  Okamoto, Mina ^a,b   Murai, Junko ^a   Imai, Yuuki ^c   Ikegami, Daisuke ^a   Kamiya, Nobuhiro ^d   Kato, Shigeaki ^c   Mishina, Yuji ^e   Yoshikawa, Hideki ^a   Tsumaki, Noriyuki ^a,b,f  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f KYOTO UNIVERSITY   (Japan)

Author keywords

bone morphogenetic protein receptor type IA; cathepsin K; coupling; osteoblasts; osteoclasts

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CATHEPSIN K; CRE RECOMBINASE; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE REMODELING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMUR; GENE DELETION; GENE LOCUS; MACROPHAGE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; SPLEEN CELL; TIBIA; TRABECULAR BONE;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE REMODELING; CELL DIFFERENTIATION; CELLS, CULTURED; GENE DELETION; MICE; OSTEOBLASTS; OSTEOCLASTS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 80053213565     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.477     Document Type: Article

References (39)

1. Olsen BR, Reginato AM, Wang W,. Bone development. Annu Rev Cell Dev Biol. 2000; 16: 191-220. (Pubitemid 32037505)
2. Boyle WJ, Simonet WS, Lacey DL,. Osteoclast differentiation and activation. Nature. 2003; 423: 337-42. (Pubitemid 40852708)
3. Pfeilschifter J, Mundy GR,. Modulation of type β transforming growth factor activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA. 1987; 84: 2024-8. (Pubitemid 17054142)
4. Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, Feng X, Van Hul W, Wan M, Cao X,. TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009; 15: 757-65.
5. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K,. Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab. 2006; 4: 111-21. (Pubitemid 44138718)
6. Matsuo K, Irie N,. Osteoclast-osteoblast communication. Arch Biochem Biophys. 2008; 473: 201-9.
7. Urist MR,. Bone: formation by autoinduction. Science. 1965; 150: 893-9.
8. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA,. Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242: 1528-34. (Pubitemid 19023695)
9. Shi Y, Massague J,. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113: 685-700. (Pubitemid 36724933)
10. Zhao M, Harris SE, Horn D, Geng Z, Nishimura R, Mundy GR, Chen D,. Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. J Cell Biol. 2002; 157: 1049-60. (Pubitemid 34839779)
11. Mishina Y, Starbuck MW, Gentile MA, Fukuda T, Kasparcova V, Seedor JG, Hanks MC, Amling M, Pinero GJ, Harada S, Behringer RR,. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling. J Biol Chem. 2004; 279: 27560-6. (Pubitemid 38812597)
12. Okamoto M, Murai J, Yoshikawa H, Tsumaki N,. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res. 2006; 21: 1022-33. (Pubitemid 43962831)
13. Sotillo Rodriguez JE, Mansky KC, Jensen ED, Carlson AE, Schwarz T, Pham L, MacKenzie B, Prasad H, Rohrer MD, Petryk A, Gopalakrishnan R,. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. J Bone Miner Res. 2009; 24: 1917-26.
14. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N,. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology. 2001; 142: 3656-62. (Pubitemid 32681777)
15. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K,. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res. 1995; 10: 1681-90.
16. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y,. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone. 2000; 27: 479-86.
17. Giannoudis PV, Kanakaris NK, Einhorn TA,. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int. 2007; 18: 1565-81. (Pubitemid 47620320)
18. Wildemann B, Kadow-Romacker A, Lubberstedt M, Raschke M, Haas NP, Schmidmaier G,. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Calcif Tissue Int. 2005; 76: 50-5. (Pubitemid 40228474)
19. Jensen ED, Pham L, Billington CJ Jr, Espe K, Carlson AE, Westendorf JJ, Petryk A, Gopalakrishnan R, Mansky K,. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. J Cell Biochem. 2010; 109: 672-82.
20. Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y,. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res. 2008; 23: 2007-17.
21. Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y,. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway. Development. 2008; 135: 3801-11.
22. Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR,. Generation of Bmpr/Alk3 conditional knockout mice. Genesis. 2002; 32: 69-72. (Pubitemid 34211699)
23. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S,. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007; 130: 811-23. (Pubitemid 47332572)
24. Iwai T, Murai J, Yoshikawa H, Tsumaki N,. Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathways. J Biol Chem. 2008; 283: 27154-64.
25. Koga T, Inui M, Inoue K, Kim S, Suematsu A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, Taniguchi T, Takayanagi H, Takai T,. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature. 2004; 428: 758-63. (Pubitemid 38508286)
26. Hanley T, Merlie JP,. Transgene detection in unpurified mouse tail DNA by polymerase chain reaction. Biotechniques. 1991; 10: 56.
27. Quinn JM, Itoh K, Udagawa N, Hausler K, Yasuda H, Shima N, Mizuno A, Higashio K, Takahashi N, Suda T, Martin TJ, Gillespie MT,. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res. 2001; 16: 1787-94. (Pubitemid 32911484)
28. Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S,. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol. 2000; 148: 333-42. (Pubitemid 30078245)
29. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Isogai Y, Suda T,. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology. 1991; 128: 1792-6.
30. Suda T, Jimi E, Nakamura I, Takahashi N,. Role of 1 alpha,25- dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 1997; 282: 223-35. (Pubitemid 27412778)
31. Horiki M, Imamura T, Okamoto M, Hayashi M, Murai J, Myoui A, Ochi T, Miyazono K, Yoshikawa H, Tsumaki N,. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol. 2004; 165: 433-45. (Pubitemid 38649917)
32. Tsumaki N, Liu Y, Yamada Y, Krebsbach P,. Enhancer analysis of the alpha 1(II) and alpha 2(XI) collagen genes in transfected chondrocytes and transgenic mice. Methods Mol Biol. 2000; 139: 187-95.
33. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, Moritz JD, Schu P, von Figura K,. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc Natl Acad Sci U S A. 1998; 95: 13453-8. (Pubitemid 28522993)
34. Lotinun S, Evans GL, Bronk JT, Bolander ME, Wronski TJ, Ritman EL, Turner RT,. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties. J Bone Miner Res. 2004; 19: 1165-71. (Pubitemid 41110569)
35. Rhee Y, Allen MR, Condon K, Lezcano V, Ronda AC, Galli C, Olivos N, Passeri G, O'Brien CA, Bivi N, Plotkin LI, Bellido T,. PTH receptor signaling in osteocytes governs periosteal bone formation and intra-cortical remodeling. J Bone Miner Res. DOI 10.1002/jbmr.304.
36. Bellido T, Ali AA, Gubrij I, Plotkin LI, Fu Q, O'Brien CA, Manolagas SC, Jilka RL,. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology. 2005; 146: 4577-83. (Pubitemid 41446595)
37. Rossert J, Eberspaecher H, de Crombrugghe B,. Separate cis-acting DNA elements of the mouse pro-alpha 1(I) collagen promoter direct expression of reporter genes to different type I collagen-producing cells in transgenic mice. J Cell Biol. 1995; 129: 1421-32.
38. Sakai K, Miyazaki J,. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun. 1997; 237: 318-24. (Pubitemid 27406027)
39. Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronenberg HM, Mishina Y,. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts. J Bone Miner Res. 25: 200-10.